Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E B Andrews

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
American Pharmacy|August 1, 1994
Acyclovir does not increase risk in pregnancyE B Andrews
Pharmacoepidemiology and Drug Safety|April 10, 2004
Data privacy, medical record confidentiality, and research in the interest of public healthE B Andrews,
Pharmacoepidemiology and Drug Safety|January 1, 1997
The re-emergence of epidemiology within the pharmaceutical industryE B Andrews,
Plastic and Reconstructive Surgery|May 1, 1970
An aid to hand rehabilitation following island flap transferE B Andrews
Epidemiology (Cambridge, Mass.)|November 3, 1998
Complexity of human immunodeficiency virus management in developing countriesA D White, E B Andrews
The Journal of Allergy and Clinical Immunology|February 9, 1999
The Pregnancy Registry program at Glaxo Wellcome CompanyA D White, E B Andrews
American Journal of Obstetrics and Gynecology|July 1, 1995
Associations between use of antenatal corticosteroids and neonatal outcomes within the Exosurf Neonatal Treatment Investigational New Drug ProgramE B Andrews, G Marcucci, A White, et al.
Journal of Medical Virology|January 1, 1993
Safety of acyclovir: a summary of the first 10 years experienceH H Tilson, C R Engle, E B Andrews
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Number of patients treated with zidovudine in the limited distribution system, March-September, 1987E B Andrews, T Creagh-Kirk, K Pattishall, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 13, 2015
Comments on Bang et al.: the impact of recombinant parathyroid hormone on malignancies and mortality: 7 years of experience based on nationwide Danish registersE B Andrews, A W Gilsenan, K D Midkiff, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
American Pharmacy|August 1, 1994
Acyclovir does not increase risk in pregnancyE B Andrews
Pharmacoepidemiology and Drug Safety|April 10, 2004
Data privacy, medical record confidentiality, and research in the interest of public healthE B Andrews,
Pharmacoepidemiology and Drug Safety|January 1, 1997
The re-emergence of epidemiology within the pharmaceutical industryE B Andrews,
Plastic and Reconstructive Surgery|May 1, 1970
An aid to hand rehabilitation following island flap transferE B Andrews
Epidemiology (Cambridge, Mass.)|November 3, 1998
Complexity of human immunodeficiency virus management in developing countriesA D White, E B Andrews
The Journal of Allergy and Clinical Immunology|February 9, 1999
The Pregnancy Registry program at Glaxo Wellcome CompanyA D White, E B Andrews
American Journal of Obstetrics and Gynecology|July 1, 1995
Associations between use of antenatal corticosteroids and neonatal outcomes within the Exosurf Neonatal Treatment Investigational New Drug ProgramE B Andrews, G Marcucci, A White, et al.
Journal of Medical Virology|January 1, 1993
Safety of acyclovir: a summary of the first 10 years experienceH H Tilson, C R Engle, E B Andrews
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Number of patients treated with zidovudine in the limited distribution system, March-September, 1987E B Andrews, T Creagh-Kirk, K Pattishall, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 13, 2015
Comments on Bang et al.: the impact of recombinant parathyroid hormone on malignancies and mortality: 7 years of experience based on nationwide Danish registersE B Andrews, A W Gilsenan, K D Midkiff, et al.
Pageof 3